Historically, it takes an average of 17 years for new treatments to move from clinical
evidence to daily practice. Given the highly effective treatments now available to prevent or …

Background: Chronic kidney disease (CKD) is an important but insufficiently recognized
public health problem. Unprecedented advances in delaying progression of CKD and …

Notable progress in basic, translational and clinical nephrology research has been made
over the past five decades. Nonetheless, many challenges remain, including obstacles to …

People living with chronic kidney disease (CKD) often experience multimorbidity and require
polypharmacy. Kidney dysfunction can also alter the pharmacokinetics and …

Patient and caregiver involvement can enhance the uptake and impact of research,
however, the involvement of patients and caregivers who are underserved and marginalized …

Prospective cohort studies of kidney equity are limited by a focus on advanced rather than
early disease and selective recruitment. Whole population studies frequently rely on area …

Rationale & Objective Almost 80% of individuals with chronic kidney disease (CKD) reside
in low-and middle-income countries (LMICs) and are potentially underrepresented in …

Simple Summary This review explores the significant differences in the diagnosis, treatment,
and outcomes of urologic cancers, including prostate, bladder, kidney, and testicular …

Use of peritoneal dialysis and home haemodialysis remains low in Europe, with the highest
use in Scandinavian countries and the lowest in Eastern and Central Europe despite the …

With the increasing frequency and severity of disasters and the increasing number of
patients living with kidney disease, on dialysis and with transplants around the world, the …